Silk Fibroin (SF) is a protein derived from silkworm silk with exceptional mechanical, biocompatible, and biodegradable properties
Market Overview
Features high tensile strength, elasticity, nontoxicity, and biocompatibility
Growth driven by increasing demand in regenerative medicine and bioengineering
Rising popularity in skincare formulations for hydration and anti-aging benefits
Market Value & Growth Projections
Market Statistics:
Global market valued at USD 96.7 million in 2022
Projected to reach USD 120.2 million by 2030
CAGR of 3.2% during forecast period
Key Market Drivers:
Growing demand in biomedical sector (artificial ligaments, wound dressings, implants)
Rising popularity in cosmetics industry for skin-rejuvenating properties
Increased R&D investments in bioengineering and regenerative medicine
Advancements in SF-based nanotechnology for drug delivery
Growing awareness about sustainable and biodegradable materials
Market Segmentation
By Type
By Application
Powdered Silk Fibroin
Film-based Silk Fibroin
Hydrogel Silk Fibroin
Biomedical (sutures, wound healing, artificial ligaments, drug delivery)
Cosmetics (skincare, haircare, anti-aging products)
Textile (high-end silk fabrics, fashion apparel)
Food Industry (food coating, protein supplement)
Key Market Players
AMSilk GmbH
Seiren Co., Ltd.
Bolt Threads Inc.
Suzhou Jingrun Biotechnology Co., Ltd.
Evolved By Nature
Regional Market Analysis
North America: US leads in SF research and commercialization; Strong focus on biomedical applications; Presence of major biotechnology firms
Europe: Key markets: Germany, France, UK; Strong research in biopolymers and bioengineering
Asia-Pacific: Largest region due to robust silk production; Key markets: China, India, Japan; Significant sericulture industry
Middle East & Africa: Emerging markets with increasing adoption
South America: Growing investments in biotechnology sector
